Dr. Wagner is a general internist/epidemiologist and Director of the W.A. MacColl Institute for Healthcare Innovation at the Group Health Research Institute. He is also Professor of Health Services at the University of Washington School of Public Health. Current research interests include the development and testing of population-based care models for diabetes, frail elderly, cancer, and other chronic illnesses; the evaluation of the health and cost impacts of chronic disease and cancer interventions, and interventions to prevent disability and reduce depressive symptoms in older adults. He has written two books and more than 200 journal articles. He serves on the editorial boards of Health Services Research, the Journal of Clinical Epidemiology, and BMJ-USA, and acts as a consultant to multiple Federal agencies and provate foundations. As of June 1998, he directs "Improving Chronic Illness Care (ICIC)", a national program of The Robert Wood Johnson Foundation. The overall goal of ICIC is to assist health systems improve their care of chronic illness through quality improvement and evaluation, research, and dissemination. He is also Principal Investigator of the Cancer Research Network, and NCI funded consortium of 10 HMOs conducting collaborative cancer effectiveness research. He served as Director of the research center at Group Health Cooperative since its inception 15 years ago and resigned in April 1998. He has turned his energy towards directing the MacColl Institute for Healthcare Innovation. This Institute, within Group Health Research Institute, is concerned with developing and evalutating health care innovations which serve the needs of the chronically ill.

Research Interests:
Health services research; Health promotion and disease prevention

SciVal Experts Profile